MGI MP annotations for MGI:2145242: Arrdc3

  • Gray arrows indicate "is_a"



    Compare annotations to MP categories for MGI:2145242.
    IDTermArrdc3Gt(CSE151)Byg
    MP:0005375adipose tissue phenotypeArrdc3Gt(CSE151)Byg
    MP:0005378growth/size phenotypeArrdc3Gt(CSE151)Byg
    MP:0005376homeostasis/metabolism phenotypeArrdc3Gt(CSE151)Byg
    MP:0005370liver/biliary system phenotypeArrdc3Gt(CSE151)Byg
    MP:0010768mortality/agingArrdc3Gt(CSE151)Byg


    Full set of annotations for MGI:2145242
    IDTermAlleleAllelesBackgroundColor Key
    MP:0001777abnormal body temperature homeostasis Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0009116abnormal brown fat cell morphology Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0005448abnormal energy balance Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0002078abnormal glucose homeostasis Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0003953abnormal hormone level Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0002118abnormal lipid homeostasis Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0001258decreased body length Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0001262decreased body weight Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0005560decreased circulating glucose level Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0002727decreased circulating insulin level Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0005668decreased circulating leptin level Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0002644decreased circulating triglyceride level Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0005479decreased circulating triiodothyronine level Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0009283decreased gonadal fat pad weight Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0005459decreased percent body fat Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0003213decreased susceptibility to age related obesity Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0002310decreased susceptibility to hepatic steatosis Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0009133decreased white fat cell size Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0002575increased circulating ketone body level Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0002891increased insulin sensitivity Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key
    MP:0011090partial perinatal lethality Arrdc3Gt(CSE151)Byg Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byginvolves: 129P2/OlaHsd * C57BL/6color key